{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "aDepartment of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, United States.",
    "bNational Cancer Center Hospital, Tokyo, Japan.",
    "cDepartment of Medical Oncology, Dana-Farber Cancer Institute Department of Medical Oncology, Massachusetts, Boston, United States.",
    "dHarvard Medical School, Massachusetts, Boston, United States.",
    "eDepartment of Medicine, Brigham and Women's Hospital, Massachusetts, Boston, United States."
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Helena A Yu"
    },
    {
      "affs": [
        1
      ],
      "name": "Yasushi Goto"
    },
    {
      "affs": [
        2,
        3,
        4
      ],
      "name": "Pasi A Jänne"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7n52yeyma9zsb.bib",
  "cited_by": 0,
  "doi": "10.1080/14796694.2026.2691681",
  "fulltext_url": "https://europepmc.org/articles/PMC13685561",
  "id": "7n52yeyma9zsb",
  "issns": [
    "1479-6694",
    "1744-8301"
  ],
  "landing_url": "https://europepmc.org/article/MED/42860885",
  "language": "eng",
  "licence": "CC-BY-NC-ND",
  "licence_label": "CC BY-NC-ND",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2740|Lung Cancer Treatments and Mutations"
    ]
  ],
  "openalex": "W7221512168",
  "pdf_url": "https://europepmc.org/articles/PMC13685561?pdf=render",
  "pmcid": "PMC13685561",
  "pmid": "42860885",
  "published": "2026-09-01",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/7n52yeyma9zsb.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:18Z",
      "native_id": "MED:42860885",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42860885"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2740|Lung Cancer Treatments and Mutations",
      "subfield": "general"
    }
  ],
  "title": "A study to learn how well HER3-DXd (patritumab deruxtecan) works and how safe it is in people with previously treated non-small-cell lung cancer that has a mutation in the EGFR gene: a plain language summary of the HERTHENA-Lung01 study.",
  "title_text": "A study to learn how well HER3-DXd (patritumab deruxtecan) works and how safe it is in people with previously treated non-small-cell lung cancer that has a mutation in the EGFR gene: a plain language summary of the HERTHENA-Lung01 study.",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:19:18Z",
  "url": "https://research.draconitic.com/paper/7n52yeyma9zsb",
  "venue": "Future oncology (London, England)",
  "versions": []
}